Why it was recalled
Lack of assurance of sterility: Suspected microbial growth present on external label packaging.
Product description
Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25
Lot numbers, UPCs & expiration codes
Lot #: AC-016581
Where it was sold
MO
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0487-2023
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Feb 8, 2023
- FDA report date
- Apr 5, 2023
- Quantity
- 215 bags
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Apollo Care
Original FDA data
Every field from FDA enforcement report D-0487-2023, exactly as published.
Show all FDA fields
- City
- Columbia
- State
- MO
- Status
- Ongoing
- Country
- United States
- Event ID
- 91674
- Address
- 3801 Mojave Ct Ste 101
- Code information
- Lot #: AC-016581
- Postal code
- 65202-4042
- Report date
- Apr 5, 2023
- Product type
- Drugs
- Recall number
- D-0487-2023
- Classification
- Class II
- Recalling firm
- Apollo Care
- Product quantity
- 215 bags
- Reason for recall
- Lack of assurance of sterility: Suspected microbial growth present on external label packaging.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25
- Distribution pattern
- MO
- Recall initiation date
- Feb 8, 2023
- Initial firm notification
- Center classification date
- Mar 24, 2023